The Roadblocks to Medical Marijuana: A Deep Dive into US Regulations
If marijuana is approved by the FDA for medicinal use and rescheduled, then for, say, schedule, where physicians could write a prescription to use marijuana in the treatment of neuropathic pain, which is one of the areas that it appears to be effective in neuropathic pain, is that kind of pain that is associated with ms fibromyalgia, other conditions that respond less well to even conventional opioids and certainly conditions that you'll have to go up in the level of heavy medication fairly early for some types of neuropathic pain, diabetes, often associated with neuropathic pain.
Ever wondered why marijuana still isn't approved for medical use in the United States? This episode from the Addiction Science Network's Podcast dives into the nitty-gritty of regulatory hurdles that marijuana faces. Set in an informal classroom discussion, the host breaks down the complexities of the Controlled Substance Act (CSA) and Drug Enforcement Administration (DEA) regulations.
You'll get an inside look at how the FDA's assessments of drug benefits and risks play a pivotal role in determining whether a substance like marijuana can be used medicinally. But that's not all; the episode also touches on the tricky business of detecting marijuana intoxication and compares the effects of marijuana pills versus smoking.
Perfect for anyone fascinated by drug addiction and psychopharmacology, this episode offers a thorough overview of the challenges and nuances in the regulation of medical marijuana. It's an eye-opener for those curious about why this controversial plant remains tightly controlled.